Perry C. Siatis, a director at AbbVie Inc. (ABBV), divested 22,381 shares of the pharmaceutical company's stock on February 27, 2026. The sale, executed at a price of $230.00 per share, amounted to approximately $5,147,630.
This transaction represents a notable sale by a key insider. While insider sales can occur for various reasons, including personal financial planning and diversification, they are closely monitored by the market for potential shifts in insider confidence.
AbbVie Inc. operates in the biopharmaceutical sector, focusing on developing and marketing innovative therapies. The company's stock performance and any insider transactions are often viewed within the context of broader market trends and sector-specific developments.